Altimmune, Inc. (ALT) Reaches $0.59 52-Week Low; Community Bank System, Inc. (CBU) Covered By 1 Bulls

May 9, 2018 - By Adrian Erickson

Community Bank System, Inc. (NYSE:CBU) Logo

The stock of Altimmune, Inc. (NASDAQ:ALT) hit a new 52-week low and has $0.53 target or 9.00% below today’s $0.59 share price. The 6 months bearish chart indicates high risk for the $10.59 million company. The 1-year low was reported on May, 9 by Barchart.com. If the $0.53 price target is reached, the company will be worth $953,190 less. The stock decreased 4.11% or $0.025 during the last trading session, reaching $0.585. About 328,798 shares traded. Altimmune, Inc. (NASDAQ:ALT) has declined 84.57% since May 9, 2017 and is downtrending. It has underperformed by 96.12% the S&P500.




Among 10 analysts covering Community Bank Systems (NYSE:CBU), 1 have Buy rating, 0 Sell and 9 Hold. Therefore 10% are positive. Community Bank Systems had 23 analyst reports since July 21, 2015 according to SRatingsIntel. The rating was upgraded by Hovde Group to “Outperform” on Wednesday, March 28. The firm has “Hold” rating given on Thursday, September 7 by RBC Capital Markets. The company was initiated on Thursday, January 7 by Piper Jaffray. RBC Capital Markets maintained Community Bank System, Inc. (NYSE:CBU) on Friday, January 22 with “Sector Perform” rating. The rating was maintained by Keefe Bruyette & Woods on Thursday, December 21 with “Hold”. The stock has “Hold” rating by RBC Capital Markets on Wednesday, April 25. The firm has “Hold” rating by Keefe Bruyette & Woods given on Monday, February 26. The rating was maintained by DA Davidson with “Neutral” on Thursday, April 26. The stock of Community Bank System, Inc. (NYSE:CBU) earned “Hold” rating by Piper Jaffray on Monday, October 23. Sandler O’Neill upgraded Community Bank System, Inc. (NYSE:CBU) on Friday, January 22 to “Buy” rating. See Community Bank System, Inc. (NYSE:CBU) latest ratings:

25/04/2018 Broker: RBC Capital Markets Rating: Hold New Target: $59.0000 Maintain
26/04/2018 Broker: DA Davidson Old Rating: Neutral New Rating: Neutral Old Target: $55 New Target: $56 Maintain
28/03/2018 Broker: Hovde Group Old Rating: Market Perform New Rating: Outperform Upgrade
26/02/2018 Broker: Keefe Bruyette & Woods Rating: Hold New Target: $57.0 Maintain
21/12/2017 Broker: Keefe Bruyette & Woods Rating: Hold New Target: $61.5 Maintain
21/12/2017 Broker: Sandler O’Neill Rating: Hold Upgrade

Community Bank System, Inc. operates as the holding firm for Community Bank, N.A. that provides various banking and financial services to retail, commercial, and municipal customers. The company has market cap of $3.03 billion. It operates through three divisions: Banking, Employee Benefit Services, and All Other. It has a 19.64 P/E ratio. The firm offers various deposits products, such as checking, savings, and money market accounts, as well as time deposits.

Investors sentiment decreased to 1.32 in 2017 Q4. Its down 0.23, from 1.55 in 2017Q3. It is negative, as 15 investors sold Community Bank System, Inc. shares while 44 reduced holdings. 18 funds opened positions while 60 raised stakes. 33.86 million shares or 2.79% less from 34.83 million shares in 2017Q3 were reported. Blackrock holds 6.53M shares. Florida-based State Board Of Administration Of Florida Retirement has invested 0% in Community Bank System, Inc. (NYSE:CBU). Howland Mngmt Ltd Liability owns 4,000 shares for 0.02% of their portfolio. Arrow Fincl Corporation stated it has 6,484 shares. Us Bancorp De, Minnesota-based fund reported 2,044 shares. Hartford Fin has invested 0.08% in Community Bank System, Inc. (NYSE:CBU). New York State Teachers Retirement System holds 137,889 shares. Shelton Cap stated it has 0.02% in Community Bank System, Inc. (NYSE:CBU). Metropolitan Life Insurance holds 15,762 shares. Gemmer Asset Lc holds 283 shares. Wells Fargo & Mn reported 0% in Community Bank System, Inc. (NYSE:CBU). Wedge Cap L Ltd Partnership Nc invested 0% of its portfolio in Community Bank System, Inc. (NYSE:CBU). Jefferies Grp Llc holds 0.01% or 40,800 shares in its portfolio. 8,045 were reported by Campbell And Adviser Ltd Liability. Moreover, Manufacturers Life Insur The has 0.01% invested in Community Bank System, Inc. (NYSE:CBU) for 153,655 shares.

Another recent and important Community Bank System, Inc. (NYSE:CBU) news was published by Seekingalpha.com which published an article titled: “Community Bank System’s (CBU) CEO Mark Tryniski on Q1 2018 Results – Earnings Call Transcript” on April 26, 2018.

Since December 5, 2017, it had 0 insider buys, and 3 insider sales for $715,754 activity. The insider MICHAEL R KALLET sold $306,270. Shares for $112,000 were sold by DICERBO NICHOLAS A on Tuesday, December 5. $297,484 worth of Community Bank System, Inc. (NYSE:CBU) was sold by DONAHUE BRIAN D.

The stock increased 0.59% or $0.35 during the last trading session, reaching $59.52. About 167,168 shares traded. Community Bank System, Inc. (NYSE:CBU) has declined 0.42% since May 9, 2017 and is downtrending. It has underperformed by 11.97% the S&P500.

More news for Altimmune, Inc. (NASDAQ:ALT) were recently published by: Globenewswire.com, which released: “Altimmune to Announce First Quarter 2018 Financial Results on May 16” on May 08, 2018. Benzinga.com‘s article titled: “Benzinga’s Daily Biotech Pulse: Portola Receives FDA Nod, Mallinckrodt Gets Thumbs Down” and published on May 04, 2018 is yet another important article.

Altimmune, Inc., a clinical stage immunotherapeutic biotechnology company, creates and develops immunotherapeutic products for treating acute respiratory infections, chronic viral infections, and cancer. The company has market cap of $10.59 million. The firm develops NasoVAX, an intranasally administered recombinant influenza vaccine that has completed Phase I clinical trials; and HepTcell, an immunotherapy for patients chronically infected with the hepatitis B virus, which is in Phase I clinical trials. It currently has negative earnings. The Company’s preclinical stage products include NasoShield, a vaccine for the prevention of anthrax disease following inhalation of pathogen spores; and Oncosyn, an immunotherapeutic for treating solid cancer indications, such as lung, colorectal, melanoma, breast, ovarian, and others.

Community Bank System, Inc. (NYSE:CBU) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.